scispace - formally typeset
W

Wynn G. Hunter

Researcher at Duke University

Publications -  14
Citations -  589

Wynn G. Hunter is an academic researcher from Duke University. The author has contributed to research in topics: Health care & Heart failure with preserved ejection fraction. The author has an hindex of 8, co-authored 14 publications receiving 417 citations. Previous affiliations of Wynn G. Hunter include Cincinnati Children's Hospital Medical Center.

Papers
More filters
Journal ArticleDOI

Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling

TL;DR: In this paper, metabolic abnormalities in heart failure were discussed with particular emphasis on the application of metabolomic profiling to detecting, risk stratifying, and identifying novel targets for metabolic therapy in this heterogeneous population.
Journal ArticleDOI

What Strategies Do Physicians and Patients Discuss to Reduce Out-of-Pocket Costs? Analysis of Cost-Saving Strategies in 1,755 Outpatient Clinic Visits

TL;DR: Despite price opacity, physicians and patients discuss a variety of out-of-pocket cost reduction strategies during clinic visits, except for switching to a lower-cost alternative and providing free samples, which are relatively consistent across health conditions.
Journal ArticleDOI

Study Of Physician And Patient Communication Identifies Missed Opportunities To Help Reduce Patients’ Out-Of-Pocket Spending

TL;DR: For consumer health care markets to work as intended, physicians need to be prepared to help patients navigate out-of-pocket expenses when financial concerns arise during clinical encounters.
Journal ArticleDOI

Discussing Health Care Expenses in the Oncology Clinic: Analysis of Cost Conversations in Outpatient Encounters.

TL;DR: Content analysis of transcribed dialogue from 677 outpatient appointments for breast cancer management identified cost conversations in approximately one in five breast cancer visits, which involved switching antineoplastic agents for lower-cost alternatives or altering logistics of diagnostic tests.